Sitavig
Product Images NDC 71403-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitavig (NDC 71403-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epi Health, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sitavig 01)

FDA Label Image

Figure A (Sitavig 02)

FDA Label Image

Figure B (Sitavig 03)

FDA Label Image

Figure C (Sitavig 04)

FDA Label Image

Figure D (Sitavig 05)

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

Principal Display Panel (50 mg Tablet Blister Pack Carton)
This text refers to a medication called Sitavie, which comes in blister packaging with 50mg buccal tablets. The medication is only available with a prescription and the instructions warn against sucking, chewing or swallowing the tablets. The packaging also includes the drug's NDC number, storage instructions, and a warning to keep the medication away from children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.